Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
CATL Stock Hits Record High After Q1 2025 Earnings Surge 
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production 
Goldman Sachs FICC Revenue Falls 10% Amid Iran War Market Volatility 
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring 
Hermès Q1 2026 Sales Miss Expectations Amid Iran War and China Slowdown 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit 
Qantas Raises Fuel Cost Forecast Amid Middle East Oil Crisis 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
SAN FRANCISCO, April 06, 2016 -- Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, today announced that company management is scheduled to present at the 15th Annual Needham Healthcare Conference on Wednesday, April 13, 2016, at 11:20 a.m. ET in New York City.
A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation.
About Invuity®
Invuity, Inc. is a medical technology company focused on developing and marketing advanced photonics devices to improve the ability of surgeons to illuminate and visualize the surgical cavity during minimally invasive and minimal access open surgery. The company's patented Intelligent Photonics™ technology enables enhanced surgical precision, efficiency and safety by providing superior visualization. Clinical applications include breast and thyroid oncology, plastic reconstructive, spine, orthopedic, cardiothoracic and general surgery among others. Invuity is headquartered in San Francisco, CA. For more information, visit www.invuity.com.
CONTACT: Company Contact: Jim Mackaness, CFO Invuity, Inc. 415-655-2100 Investors: Matt Clawson Pure Communications 949-370-8500 [email protected]
